Amarin Corporation(AMRN) - 2026 Q2 - Earnings Call Presentation

AMARIN, VASCEPA, VAZKEPA and REDUCE-IT are trademarks of Amarin Pharmaceuticals Ireland Limited. VAZKEPA is a registered trademark in Europe and other countries and regions and is pending registration in the United States. AT THE HEART OF IMPROVED CARDIOVASCULAR OUTCOMES COMPANY OVERVIEW NASDAQ: AMRN | JULY 2026 PLACEHOLDER FOR HERO IMAGE Replace with licensed photography AMARIN LOGO Forward Looking Statements & Disclaimer This presentation contains forward-looking statements, such as those relating to the ...

Amarin Corporation(AMRN) - 2026 Q2 - Earnings Call Presentation - Reportify